Please Enable Cookies

www.cablinginstall.com is using a security service for protection against online attacks. This process is automatic. You will be redirected once the validation process is complete.

Recent Quotes
My Watchlist
Indicators
Cabling Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Electrocore Inc (NQ: ECOR )

6.550 -0.110 (-1.65%)
Streaming Delayed Price Updated: 3:52 PM EDT, Jun 7, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Electrocore Inc

< Previous 1 2 3 4 Next >
ECOR Stock Earnings: electroCore Beats EPS, Beats Revenue for Q1 2024
ECOR stock results show that electroCore beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Earnings Scheduled For March 13, 2024
Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share on revenue of $8.10 million. 
Via Benzinga
A Preview Of electroCore's Earnings
Via Benzinga
electroCore Earnings Perspective: Return On Capital Employed
Via Benzinga
iAccess Alpha Best Ideas from the Buyside Virtual Conference - Sep 26th-27th 2023
Via ACCESSWIRE
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
DBV Technologies And 3 Other Penny Stocks Insiders Are Buying
The Dow Jones closed lower by over 60 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
electroCore: Q1 Earnings Insights
Via Benzinga
Electrocore Inc. (NASDAQ: ECOR) Near the Top of Equities by Percentage Gain on 3/24
Via Investor Brand Network
NFL-Funded Study: CBD Or Non-Invasive Vagal Nerve Stimulation - Which Is Better To Alleviate Concussion Symptoms
electroCore, Inc.’s (NASDAQ: ECOR) gammaCore non-invasive vagus nerve stimulation (“nVNS”) has been selected to be a part of studies on effects of cannabinoids and alternative care on athlete pain... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
electroCore's Truvaga Users Reported Improved Stress, Anxiety, Sleep, Energy and Mood in Recent Focus Group Study
From electroCore, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
electroCore Earnings Perspective: Return On Capital Employed
Via Benzinga
A Preview Of electroCore's Earnings
Via Benzinga
electroCore Reports Results of Pre-Clinical Trial in a Model of Traumatic Brain Injury
Pre-clinical trial demonstrates the ability of nVNS to decrease the amount of brain injury, decrease anxiety and improve motor function post injury 
From electroCore, Inc.
Via GlobeNewswire
electroCore Affirms No Direct Exposure to Silicon Valley Bank, Silvergate Bank, or Signature Bank
From electroCore, Inc.
Via GlobeNewswire
electroCore Announces Poster to be Presented at the 2023 American Academy of Neurology Annual Scientific Meeting
Poster Highlights the Ability of Non-Invasive Vagus Nerve Stimulation (nVNS) to Accelerate Learning of a Second Language 
From electroCore, Inc.
Via GlobeNewswire
electroCore to Participate at 35th Annual Roth Conference
From electroCore, Inc.
Via GlobeNewswire
Earnings Scheduled For March 8, 2023
Companies Reporting Before The Bell • Daktronics (NASDAQ:DAKT) is expected to report quarterly earnings at $0.00 per share on revenue of $164.68 million. 
Via Benzinga
electroCore Regains Compliance with Nasdaq Listing Requirements
From electroCore, Inc.
Via GlobeNewswire
electroCore to Announce Fourth Quarter and Year Ended December 31, 2022 Financial Results on Wednesday, March 8
From electroCore, Inc.
Via GlobeNewswire
7 Stocks to Sell as Borrowing Costs Rise
With new economic data boding poorly for risk-on investments, investors should strongly consider targeting stocks to sell. 
Via InvestorPlace
10 Short Squeeze Candidates: Getty Images, Genius Brands, Lannett And More
Potential short squeeze plays gained steam in 2021 and continued through 2022, with new traders looking for the next huge move. High short interest and a high cost to borrow are among the common traits... 
Via Benzinga
electroCore, Inc. Announces Exclusive Distribution Agreement with Byond Healthcare Pty Ltd, South Africa
From electroCore, Inc.
Via GlobeNewswire
electroCore Expands Intellectual Patent Portfolio for nVNS Technology
From electroCore, Inc.
Via GlobeNewswire
electroCore Completes Sale of New Jersey Tax Benefits
From electroCore, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.